Market Overview - The Legal Cannabis Market has grown from USD 33.52 billion in 2024 to USD 42.91 billion in 2025, with a projected value of USD 144.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 27.52% [2][11]. - The market evolution is driven by legislative changes, consumer behavior, and technological advancements [2]. Industry Dynamics - Legislative changes and increasing consumer acceptance have led to a diverse range of products, including extracts and edibles, while regulatory bodies are enhancing quality control measures [3]. - Vertical integration and partnerships are essential for achieving scale and distribution advantages, with advances in cultivation improving yields and consistency [4]. - Federal developments are fostering optimism regarding interstate commerce and harmonized licensing and taxation frameworks [5]. Investment Trends - There is a noticeable shift towards ancillary services and strategic mergers and acquisitions, which are reshaping competitive landscapes and refining value creation across the supply chain [6]. - Decision-makers are gaining strategic insights to identify opportunities amid evolving consumer preferences and technological advancements [6]. Tariff Impact - New tariff structures in 2025 have increased costs for cultivation and processing, leading to reassessments of manufacturing locations and supplier networks [8]. - Retailers are facing margin pressures due to increased duties on imported machinery and packaging components, often passing costs to consumers [9]. - Regional operators are diversifying sourcing strategies to mitigate future tariff effects, fostering collaborative partnerships to maintain resilience [9]. Key Report Attributes - The report spans 193 pages, covering the forecast period from 2025 to 2030, with an estimated market value of USD 42.91 billion in 2025 and a forecasted value of USD 144.18 billion by 2030 [11].

Core Insights - Cresco Labs (CRLBF) is facing persistent challenges in the U.S. cannabis market despite being a leading vertically integrated operator [1][2] - The company reported a 10% year-over-year decline in revenues for Q1 2025, totaling $165.8 million, amid restrictive federal laws and fragmented state regulations [3][9] - Adjusted gross margin decreased to 49.3%, down 220 basis points year-over-year, while adjusted EBITDA margins contracted to nearly 22% from 28.8% [4][9] - The company anticipates further revenue pressure in Q2 due to a mandatory system transition in Illinois, despite ongoing expansion efforts [5][9] - Cresco's stock has declined 24% year-to-date, contrasting with a 6% rise in the industry [8] Company Performance - Cresco's revenues are solely generated from the U.S., making it vulnerable to domestic market challenges [2] - The company generated $30 million in operating cash flow, but profitability is under pressure from rising costs [4] - Loss estimates for 2026 and 2027 have widened over the past 60 days, indicating ongoing financial difficulties [11] Competitive Landscape - Cresco faces stiff competition from peers like Aurora Cannabis, Canopy Growth, and Tilray Brands, which are also pursuing expansion and cost-optimization strategies [6] - Competitors are diversifying their revenue streams internationally, giving them an edge over Cresco, which remains reliant on the saturated U.S. market [7] Future Outlook - The company's turnaround is contingent on a broader regulatory shift in the U.S., which remains uncertain in the near term [12] - Despite operational discipline and free cash flow generation, the stock is considered to have limited upside and elevated risk for conservative investors [12]

TALLAHASSEE, Fla., July 11, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the launch of Redemption Cannabis products at Trulieve dispensaries in West Virginia.Redemption Cannabis, founded by industry advocate Ryan Basore, reinvests a portion of every sale to support individuals and families impacted by cannabis prohibition laws. Redemption's mission stems from Basore's commitme ...

TORONTO and GLIL YAM, Israel, July 11, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the "Shelf Registration") on Form F-3 with the Securities and Exchange Commission ("SEC").The Shelf Registration will allow the Company to offer and sell, from time to time, up to an aggregate of $50 million of its common shares, wa ...

Group 1: Canopy Growth - Canopy Growth has been a disappointing investment over the past five years, with a significant decline in net revenue and increased losses per share [3][4] - The cannabis industry faces challenges such as legal and regulatory issues, competition from illicit markets, and oversupply, particularly in Canada [5][6] - Despite cost-cutting efforts and a focus on in-demand products, the long-term outlook for Canopy Growth remains bleak, with expectations of further stock decline [6][7] Group 2: Novavax - Novavax reported substantial revenue growth in the first quarter, with revenue of $666.7 million and a net income of $518.6 million, a significant improvement from the previous year [8] - The company has positive results from phase 3 studies for its influenza and combination COVID-19 vaccines, along with partnerships with major pharmaceutical companies [8][9] - However, the long-term sustainability of Novavax's performance is questionable due to market unpredictability, competition from leaders like Moderna and Pfizer, and reliance on external funding for future trials [10][12][13]

Core Viewpoint - Rubicon Organics Inc. is set to hold its Annual General and Special Meeting on July 31, 2025, to discuss various corporate matters including financial statements and director elections [1][2]. Company Overview - Rubicon Organics is a leading Canadian producer of certified organic and premium cannabis, with a vertically integrated model and a strong national distribution network [4]. - The company is scaling trusted brands such as Simply Bare™ Organics and 1964 Supply Co.™, supported by its Delta, BC Facility and the newly acquired Hope, BC Facility, which will increase production capacity by over 40% [5]. Financial and Operational Highlights - The company has demonstrated consistent revenue growth and positive Adjusted EBITDA, driven by a focus on premium quality, innovation, and operational execution [6]. - Rubicon Organics is positioned to capitalize on the increasing global demand for high-quality cannabis, distinguishing itself through brand equity and consumer loyalty [6]. Meeting Agenda - The Meeting will cover the following key items: 1. Review of audited financial statements for the year ended December 31, 2024 [8]. 2. Setting the number of directors at eight [8]. 3. Election of directors for the upcoming year [8]. 4. Appointment of PricewaterhouseCoopers LLP as auditors and authorization for directors to fix their remuneration [8]. 5. Consideration of an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance [8]. 6. Discussion of any other business that may properly come before the Meeting [8].

Company Overview - SNDL Inc. is one of the largest vertically integrated cannabis companies in Canada and the largest private-sector liquor and cannabis retailer [2] - The company operates various retail banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Superette [2] - SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Vacay, Pearls by Grön, No Future, and Bhang Chocolate [2] Financial Results Announcement - SNDL will release its second quarter 2025 financial results for the period ended June 30, 2025, before market opens on July 31, 2025 [1] - A conference call and webcast will be hosted by SNDL at 10:00 a.m. EDT (8:00 a.m. MDT) on July 31, 2025, following the release of the financial results [1]

Sacramento, California, July 10, 2025 (GLOBE NEWSWIRE) -- In a moment that marks not just a milestone for a brand, but a turning point for every cannabis user, Yocan Black proudly announces the release of two revolutionary innovations: the Cloud³ Chamber and the Pocket Smart Wax Pen. Together, they redefine how flavor, power, and precision can exist in harmony—raising the standard for concentrate vaporizers across the industry. From the Company That Set the Standard—Comes the Next One For over a decade, Yo ...

Core Viewpoint - TerrAscend Corp. will host a conference call to discuss its second quarter financial results for 2025 on August 7, 2025, after market close [1] Group 1: Conference Call Details - The conference call is scheduled for Thursday, August 7, 2025, at 5:00 p.m. Eastern Time [2] - A webcast will be available at https://app.webinar.net/0K9b289Jyd7 [2] - The dial-in number for the call is 1-888-510-2154, with a replay available until midnight Eastern Time on August 21, 2025 [2] Group 2: Company Overview - TerrAscend is a leading cannabis company listed on TSX, with operations across North America, including states like Pennsylvania, New Jersey, Maryland, Ohio, Michigan, and California [3] - The company operates retail locations such as The Apothecarium and Gage, along with cultivation, processing, and manufacturing facilities [3] - TerrAscend offers a wide range of high-quality cannabis products for both medical and legal adult-use markets, owning or licensing several brands including Gage Cannabis, Cookies, and Wana [3]

NEW YORK, July 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Thursday, August 7, 2025, at 5:00 PM ET following the release of its second quarter 2025 financial results. The earnings conference call may be accessed by dialing 1-888-699-1199. A live webcast will also be available on the Investor Relations section of the AWH w ...